The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
ruxolitinib · Tablet
16 marketed package NDCs · 3 active manufacturers
Most dispensed: PHOSPHATE 15 mg/g · Cream · #1 tube/carton / 60 g in 1 tube
What changed in the last 90 days
Every detected change for ruxolitinib, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Same drug class
Other molecules FDA puts in Janus Kinase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Ruxolitinib in shortage right now?
- No. FDA does not currently list Ruxolitinib in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Ruxolitinib?
- 4 companies have marketed Ruxolitinib in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Ruxolitinib cost?
- The typical pharmacy pays about $34.00 per gram, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.